ILKO Pharmaceuticals aims to be a leading company in global competition with all its production and R&D investments by offering 'innovative' products that improve people's quality of life and save lives by using advanced technologies required by modern medicine. İLKO Pharmaceuticals has a broad product portfolio covering all major therapeutic areas. It also operates in the fields of biotechnology and consumer health (Wellcare). İLKO Pharmaceuticals is one of the top 10 pharmaceutical companies in Turkey with the highest R&D expenditures. It has a strong R&D structure and has two separate R&D Centers. ILKO Argem R&D Center, located in Hacettepe Teknopark, is working on the development of advanced technology-based and value-added products as well as small molecule generic products, İLKO Argem Biotechnology Center, Turkey's first biotechnology R&D Center, continues its activities to develop biotechnological drugs using recombinant DNA technology as a tool. The Center currently conducts R&D and clinical studies on biosupers, biosimilars and new generation biotechnological products. İt is planned to be in the market with non sterile high potent products as of Jan’23. İLKO Pharmaceuticals make strategic partnership with global companies and exports own products to 40 countries.

Our company is import and distributor company by our dealer distributors around Turkey for our represented brands CARLO ERBA Reagents, CARL ROTH and ABCR for laboratory research chemicals and pharmaceutical excipients, also brands SIMAX, KARTELL, ROTH, LLG and VWR for consumables.

It is the Turkish distributor of industry-leading brands of European and American origin in the fields of laboratory and production devices and consumables. In addition to providing consultancy services with pre- and post-sales planning and analysis, it also has a certified technical service team that has completed on-site training for all of the brands in its portfolio.

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives.   Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to make the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our commitments. We are one of the largest pharmaceutical companies in Turkey, serving public health with more than 1,600 employees. Adding value to local economy and development in Turkey, we offer a broad range of products including innovative therapeutic solutions, biotechnological pharmaceuticals, vaccines, and consumer healthcare products.

As a company operating in a sector where human health is the primary essence, the vision of Selçuk Ecza Deposu is to provide services designed at global standards required by our time for its local and foreign customers at a national and international level, to improve and diversify its services, and to perform even better than what's expected of it when people's well-being is concerned by analyzing all the dynamics of a sector focused on human health. The mission of Selçuk Ecza Deposu is to maintain its leadership in its industry by analyzing the dynamics of the sector well, maintain its reputation as a reliable organization providing quality services as a point of access between pharmacies and drug suppliers, and provide for the needs, demands and expectations of its customers by offering the widest range of products with the most favorable commercial terms and state of-theart technology, in accordance with "Good Distribution Method" principles.